Veradermics Ownership | Who Owns Veradermics?
Veradermics Ownership Summary
Veradermics is owned by 4.49% institutional investors, 2.74% insiders, and 92.78% retail investors. Suvretta capital management is the largest institutional shareholder, holding 2.07% of MANE shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 2.27% of its assets in Veradermics shares.
MANE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Veradermics | 4.49% | 2.74% | 92.78% |
| Sector | Healthcare Stocks | 35.75% | 11.89% | 52.37% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Suvretta capital management | 4.17M | 2.07% | $263.27M |
| Sr one capital management, lp | 2.40M | 1.19% | $151.68M |
| Citadel advisors | 1.83M | 0.91% | $115.29M |
| Fmr | 1.79M | 0.89% | $113.22M |
| Viking global investors lp | 1.69M | 0.84% | $106.76M |
| Siren | 1.51M | 0.75% | $95.06M |
| Adage capital partners gp | 1.10M | 0.55% | $69.47M |
| Abrdn | 1.05M | 0.52% | $66.60M |
| Jpmorgan chase | 976.17K | 0.48% | $59.40M |
| Infinitum asset management | 731.15K | 0.36% | $46.17M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Sr one capital management, lp | 2.40M | 16.57% | $151.68M |
| Suvretta capital management | 4.17M | 6.72% | $263.27M |
| Infinitum asset management | 731.15K | 5.77% | $46.17M |
| Siren | 1.51M | 2.64% | $95.06M |
| Catalio capital management, lp | 173.58K | 2.29% | $10.96M |
| Monashee investment management | 50.00K | 1.72% | $3.16M |
| Vivo capital | 300.00K | 1.58% | $18.95M |
| Myda advisors | 120.00K | 1.25% | $7.58M |
| Paradigm biocapital advisors lp | 525.00K | 0.68% | $33.15M |
| Deep track capital, lp | 500.00K | 0.52% | $31.57M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Suvretta capital management | 4.17M | 6.72% | 4.17M |
| Sr one capital management, lp | 2.40M | 16.57% | 2.40M |
| Citadel advisors | 1.83M | 0.02% | 1.83M |
| Fmr | 1.79M | 0.01% | 1.79M |
| Viking global investors lp | 1.69M | 0.30% | 1.69M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Royal bank of canada | 8.00 | - | 8.00 |
| Tower research capital llc (trc) | 10.00 | - | 10.00 |
| Jones financial companies lllp | 10.00 | - | 10.00 |
| Sbi securities | 20.00 | - | 20.00 |
| Nvwm | 35.00 | 0.00% | 35.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Suvretta capital management | 4.17M | 6.72% | 4.17M | $263.27M |
| Sr one capital management, lp | 2.40M | 16.57% | 2.40M | $151.68M |
| Citadel advisors | 1.83M | 0.02% | 1.83M | $115.29M |
| Fmr | 1.79M | 0.01% | 1.79M | $113.22M |
| Viking global investors lp | 1.69M | 0.30% | 1.69M | $106.76M |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 37 | - | 9,030,887 | - | 4 | - | 37 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 949.08K | 2.27% | 165.35K |
| Vanguard Total Stock Mkt Idx Inv | 620.12K | 1.66% | 115.41K |
| Fidelity Growth Company Fund | 625.76K | 1.50% | 35.60K |
| abrdn Healthcare Opportunities | 353.72K | 0.95% | 817.00 |
| abrdn Healthcare Investors | 378.00K | 0.90% | - |
| JPMorgan Small Cap Growth A | 313.97K | 0.75% | -162.45K |
| abrdn World Healthcare | 199.55K | 0.53% | -892.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 196.45K | 0.53% | 17.75K |
| MEDICAL BioHealth EUR Acc | 190.10K | 0.51% | 106.17K |
| Fidelity Growth Company K6 | 176.77K | 0.42% | 9.65K |
MANE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools